Rhythm Pharmaceuticals Balance Sheet Analysis

Assets, liabilities, and stockholders equity in billions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Rhythm Pharmaceuticals, Inc. (RYTM) - Annual data in billions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Current Assets
Cash and Cash Equivalents0.090.060.330.290.100.290.25
Short-Term Investments0.230.220.210.240.070.000.00
Cash & Short-Term Investments0.320.280.330.290.170.290.25
Accounts Receivable0.020.010.010.000.000.000.00
Inventory0.020.010.000.000.000.000.00
Other Current Assets0.020.010.010.000.000.000.00
Total Current Assets0.370.310.350.310.180.300.26
Non-Current Assets
Property, Plant & Equipment (Net)0.000.000.000.000.010.000.00
Intangible Assets0.010.010.010.000.000.000.00
Other Non-Current Assets0.000.000.020.010.000.230.00
Total Non-Current Assets0.020.020.030.020.010.000.00
Total Assets0.390.330.380.330.190.310.26
Current Liabilities
Accounts Payable0.010.000.040.040.000.020.01
Short-Term Debt0.000.000.000.000.000.000.00
Current Portion of Long-Term Debt0.000.000.000.000.000.000.00
Accrued Liabilities0.060.040.030.030.010.000.00
Deferred Revenue0.000.000.000.010.000.000.00
Other Current Liabilities0.040.010.000.000.000.000.00
Total Current Liabilities0.120.060.040.040.020.020.01
Non-Current Liabilities
Long-Term Debt0.110.110.000.000.000.000.00
Other Non-Current Liabilities0.110.000.000.000.000.000.00
Total Non-Current Liabilities0.110.110.080.000.000.000.00
Total Liabilities0.230.160.120.050.020.030.01
Stockholders' Equity
Common Stock0.000.000.000.000.000.000.00
Retained Earnings-1.16-0.89-0.71-0.53-0.46-0.33-0.18
Accumulated Other Comprehensive Income0.000.000.000.000.000.000.00
Additional Paid-in Capital1.181.060.970.810.630.610.43
Shares Outstanding0.060.060.060.050.000.000.00
Total Stockholders' Equity0.160.170.260.280.170.280.25
Total Liabilities & Equity0.390.330.380.330.190.310.26